About 1/8 of global deaths are due to some sort of bacterial infection, pretty close behind cancer ( 1/6 ).
However for children the number that die of infection in the UK is double that of cancer deaths - ( ~15% versus ~7% ) - and that's in an advanced economy.
Infection is a big problem.
In terms of barriers to making treatments - yes in part there is a problem with the right financial incentives - but it's not the only problem - finding molecules that simultaneously kill bacteria, won't be rapidly evolved around, and are safe to take isn't that easy. Then you have the problem of selectivity between bacteria - how many different sorts will it work with - 'good' verus 'bad' bacteria etc. Then you have the problem of being able to make the molecule at scale etc.
The good news is there is a constant bacteria on bacteria, fungus on bacteria chemical war going on - hence the paper.
> ( ~15% versus ~7% ) - and that's in an advanced economy.
There were 1,507 infection related child deaths between 1 April 2019 and 31 March 2022 (3 years); an overall rate of 4.20 deaths per 100,000 children per year. This was the equivalent of 15% of all child deaths in this period.
Overall, in 90% of the infection related deaths the child had an underlying health condition, including 68% who had a life-limiting condition (e.g., cerebral palsy), and 22% who had another underlying health condition (including prematurity). 10% had no underlying health condition.
In children where infection provided a complete and sufficient explanation of death, nearly a quarter (24%) had no underlying health condition.
We could definitely do more - one of the challenges here is that some bacteria are quite picky about where they grow - ie there a lots that don't grow on a petri dish. So not always so easy to grow side by side.
Note from the paper - they stored the soil samples for a year on growth media before testing ( to allow any compunds to build up presumably ). That doesn't sound like a fast process.
Our knowledge of what's out there is quite biased by what grows well in the lab - probably less than 1% of all bacteria will grow on an agar plate.
However for children the number that die of infection in the UK is double that of cancer deaths - ( ~15% versus ~7% ) - and that's in an advanced economy.
Infection is a big problem.
In terms of barriers to making treatments - yes in part there is a problem with the right financial incentives - but it's not the only problem - finding molecules that simultaneously kill bacteria, won't be rapidly evolved around, and are safe to take isn't that easy. Then you have the problem of selectivity between bacteria - how many different sorts will it work with - 'good' verus 'bad' bacteria etc. Then you have the problem of being able to make the molecule at scale etc.
The good news is there is a constant bacteria on bacteria, fungus on bacteria chemical war going on - hence the paper.